Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioSig Technologies Inc. BSGM

BioSig Technologies Inc is a commercial stage medical device company. It is developing a proprietary technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:BioSig to Participate in Benzinga All Access Event: Dec 14th

The presentation will be broadcast live at 9:40 am EST on Tuesday, December 14th, 2021. To watch the live event, please click here.  rate and reply

BioSig to Participate in Benzinga All Access Event: Dec 14th

" I look forward to sharing some of those highlights including first commercial sales, the completion of approximately 1800 patient cases with the PURE EP™ System, and the launching of several...read more

Seeking Alpha Poured Cold Water on it

BioSig makes record gains after exceeding procedural target for 2021 BioSig Technologies (BSGM +19.6%) has climbed to post the biggest intraday gain since April 2020 after the company announced that...read more

RE:Laidlaw Securities $17 Target

https://player.fm/series/proactive-interviews-for-investors/biosig-technologies-taps-medical-device-industry-executive-james-barry-as-independent-board-director  rate and reply